Walgreens Boots Alliance

Walgreens forms Patient Advisory Board to increase representation in clinical trials, leveraging patient insights for better recruitment and retention in community-centered research.

Walgreens forms Patient Advisory Board to boost representation in clinical trials, aiming to enhance recruitment and retention in historically excluded communities.

Walgreens launched its inaugural Clinical Trials Patient Advisory Board, comprising 10 patient experts serving 2-year terms to enhance representation in clinical research, focusing on historically excluded communities. Since June 2022, the Clinical Trials team has reached over 7 million patients for potential recruitment into sponsor-led trials, addressing challenges where only 5% of the U.S. population participates in clinical trials, and nearly 80% of trials fail to meet enrollment goals.

Walgreens launched its clinical trial business in June 2022, leveraging its national retail pharmacy network for patient recruitment, trial conduct, and real-world evidence services. The company has expanded its services, focusing on insights-driven patient recruitment, trial conduct, and real-world evidence informatics. Walgreens has successfully enrolled diverse patient populations in various trials, addressing historical underrepresentation in research. The company aims to continue its role in decentralizing clinical research, making trials more accessible and representative.